Terms: = Breast cancer AND TET1, KIAA1676, 80312, ENSG00000138336, CXXC6, bA119F7_1, Q8NFU7, LCX AND Treatment
47068 results:
1. Development and validation of a nomogram for predicting the occurrence of renal dysfunction after treatment of immune checkpoint inhibitor: a retrospective case-control study.
Su J; Chen P; Yang Y; Gao Z; Bi Z; Feng M
BMJ Open; 2024 May; 14(5):e082484. PubMed ID: 38760047
[TBL] [Abstract] [Full Text] [Related]
2. Overall survival after mastectomy versus breast-conserving surgery with adjuvant radiotherapy for early-stage breast cancer: meta-analysis.
Rajan KK; Fairhurst K; Birkbeck B; Novintan S; Wilson R; Savović J; Holcombe C; Potter S
BJS Open; 2024 May; 8(3):. PubMed ID: 38758563
[TBL] [Abstract] [Full Text] [Related]
3. Dynamic Projection of Medication Nonpersistence and Nonadherence Among Patients With Early breast cancer.
Rinder P; Marcille T; Sinel-Boucher P; Cals-Maurette M; Kanoun D; Levy C; Teixeira L; Hornus P; Szeftel D; Heudel PE
JAMA Netw Open; 2024 May; 7(5):e2411909. PubMed ID: 38758553
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic factors for the development of upper limb dysfunctions after breast cancer: the UPLIFT-BC prospective longitudinal cohort study protocol.
De Groef A; Vets N; Devoogdt N; Smeets A; Van Assche D; Emmerzaal J; Dams L; Verbeelen K; Fieuws S; Baets L
BMJ Open; 2024 May; 14(5):e084882. PubMed ID: 38754876
[TBL] [Abstract] [Full Text] [Related]
5. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
Salim N; Tumanova K; Popodko A; Libson E
JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathologic features and genomic profiling of female axillary lymph node metastases from adenocarcinoma or poorly differentiated carcinoma of unknown primary.
Tang L; Zhu Y; Du Y; Long X; Long Y; Tang Y; Liu J
J Cancer Res Clin Oncol; 2024 May; 150(5):256. PubMed ID: 38750402
[TBL] [Abstract] [Full Text] [Related]
7. Practice of breast self-examination and associated factors among women of reproductive age in the North Shoa Zone, Oromia, Ethiopia, 2022: a convergent mixed-methods study.
Hussein D; Oyato BT; Gashaw K; Geleta TA; Tufa DG; Geleta LA
BMJ Open; 2024 May; 14(5):e073951. PubMed ID: 38749697
[TBL] [Abstract] [Full Text] [Related]
8. Symptoms, concerns, and experiences of women living with and beyond breast cancer in Africa: A mixed-methods systematic review.
Asuquo EO; Absolom K; Ebenso B; Allsop MJ
Psychooncology; 2024 May; 33(5):e6342. PubMed ID: 38747633
[TBL] [Abstract] [Full Text] [Related]
9. Exploration of poly (ADP-ribose) polymerase inhibitor resistance in the treatment of BRCA1/2-mutated cancer.
Wu S; Yao X; Sun W; Jiang K; Hao J
Genes Chromosomes Cancer; 2024 May; 63(5):e23243. PubMed ID: 38747337
[TBL] [Abstract] [Full Text] [Related]
10. The usage and costs of national drug price-negotiated anticancer medicines in a first-tier city in Northeast China: a study based on health insurance data.
Li BX; Wang YQ; Yi YY; Zhou N; Lv ZX; Ma R; Li X; Yuan N
BMC Public Health; 2024 May; 24(1):1309. PubMed ID: 38745323
[TBL] [Abstract] [Full Text] [Related]
11. An Immersive Virtual Reality Intervention for Preoperative Anxiety and Distress Among Adults Undergoing Oncological Surgery: Protocol for a 3-Phase Development and Feasibility Trial.
El-Gabalawy R; Sommer JL; Hebbard P; Reynolds K; Logan GS; Smith MSD; Mutter TC; Mutch WA; Mota N; Proulx C; Gagnon Shaigetz V; Maples-Keller JL; Arora RC; Perrin D; Benedictson J; Jacobsohn E
JMIR Res Protoc; 2024 May; 13():e55692. PubMed ID: 38743939
[TBL] [Abstract] [Full Text] [Related]
12. Exploring novel immunotherapy biomarker candidates induced by cancer deformation.
Kim SM; Park N; Park HB; Lee J; Chun C; Kim KH; Choi JS; Kim HJ; Choi S; Lee JH
PLoS One; 2024; 19(5):e0303433. PubMed ID: 38743676
[TBL] [Abstract] [Full Text] [Related]
13. Leveraging G-CSF prescribing in the outpatient setting: considerations beyond clinical factors-a questionnaire study.
Scotté F; Artru P; Saghatchian M; Chouaid C
Support Care Cancer; 2024 May; 32(6):347. PubMed ID: 38743147
[TBL] [Abstract] [Full Text] [Related]
14. Neoadjuvant radiotherapy in ER
Bruss C; Albert V; Seitz S; Blaimer S; Kellner K; Pohl F; Ortmann O; Brockhoff G; Wege AK
Front Immunol; 2024; 15():1355130. PubMed ID: 38742103
[TBL] [Abstract] [Full Text] [Related]
15. Phytochemical study of
Moraes ARA; Siqueira EP; Kohlhoff M; Evangelista FCG; Sabino AP; Vieira Filho SA; Alcântara AFC; Duarte LP; Sousa GF
Nat Prod Res; 2024 Jun; 38(11):1956-1960. PubMed ID: 38739565
[No Abstract] [Full Text] [Related]
16. Tabersonine enhances cisplatin sensitivity by modulating Aurora kinase A and suppressing epithelial-mesenchymal transition in triple-negative breast cancer.
Chen X; Yan Y; Liu Y; Yi Q; Xu Z
Pharm Biol; 2024 Dec; 62(1):394-403. PubMed ID: 38739003
[TBL] [Abstract] [Full Text] [Related]
17. Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery.
Sturniolo I; Váróczy C; Bede ÁM; Hegedűs C; Demény MÁ; Virág L
J Vis Exp; 2024 Apr; (206):. PubMed ID: 38738886
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial.
Man X; Huang J; Sun S; Zhou D; Zhang B; Fang S; Zheng F; Li C; Wang X; Huang W; Wang L; He Q; Fu H; Zhang Y; Liu C; Dong L; Zhao X; Xu L; Sun X; Fan B; Song L; Zhou Z; Yu J; Li H
Clin Transl Med; 2024 May; 14(5):e1687. PubMed ID: 38738791
[TBL] [Abstract] [Full Text] [Related]
19. A dosiomics model for prediction of radiation-induced acute skin toxicity in breast cancer patients: machine learning-based study for a closed bore linac.
Saadatmand P; Mahdavi SR; Nikoofar A; Jazaeri SZ; Ramandi FL; Esmaili G; Vejdani S
Eur J Med Res; 2024 May; 29(1):282. PubMed ID: 38735974
[TBL] [Abstract] [Full Text] [Related]
20. SEEI: spherical evolution with feedback mechanism for identifying epistatic interactions.
Tang DY; Mao YJ; Zhao J; Yang J; Li SY; Ren FX; Zheng J
BMC Genomics; 2024 May; 25(1):462. PubMed ID: 38735952
[TBL] [Abstract] [Full Text] [Related]
[Next]
